206 related articles for article (PubMed ID: 15193377)
1. A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice.
Morton M; Garmory HS; Perkins SD; O'Dowd AM; Griffin KF; Turner AK; Bennett AM; Titball RW
Vaccine; 2004 Jun; 22(20):2524-32. PubMed ID: 15193377
[TBL] [Abstract][Full Text] [Related]
2. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
[TBL] [Abstract][Full Text] [Related]
3. Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague.
Garmory HS; Griffin KF; Brown KA; Titball RW
Vaccine; 2003 Jun; 21(21-22):3051-7. PubMed ID: 12798649
[TBL] [Abstract][Full Text] [Related]
4. Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague.
Yang X; Hinnebusch BJ; Trunkle T; Bosio CM; Suo Z; Tighe M; Harmsen A; Becker T; Crist K; Walters N; Avci R; Pascual DW
J Immunol; 2007 Jan; 178(2):1059-67. PubMed ID: 17202369
[TBL] [Abstract][Full Text] [Related]
5. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.
Sanapala S; Rahav H; Patel H; Sun W; Curtiss R
Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051
[TBL] [Abstract][Full Text] [Related]
6. Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge.
Liu WT; Lin WT; Tsai CC; Chuang CC; Liao CL; Lin HC; Hung YW; Huang SS; Liang CC; Hsu HL; Wang HJ; Liu YT
Vaccine; 2006 Jul; 24(31-32):5852-61. PubMed ID: 16759760
[TBL] [Abstract][Full Text] [Related]
7. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD
Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052
[TBL] [Abstract][Full Text] [Related]
8. Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen.
Garmory HS; Freeman D; Brown KA; Titball RW
Vaccine; 2004 Feb; 22(8):947-57. PubMed ID: 15161071
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
10. A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen.
Liu WT; Hsu HL; Liang CC; Chuang CC; Lin HC; Liu YT
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):58-69. PubMed ID: 17640293
[TBL] [Abstract][Full Text] [Related]
11. Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice.
Torres-Escobar A; Juárez-Rodríguez MD; Gunn BM; Branger CG; Tinge SA; Curtiss R
Infect Immun; 2010 Jun; 78(6):2529-43. PubMed ID: 20308296
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague.
Titball RW; Howells AM; Oyston PC; Williamson ED
Infect Immun; 1997 May; 65(5):1926-30. PubMed ID: 9125581
[TBL] [Abstract][Full Text] [Related]
13. [Protective activity of the recombinant strain Salmonella minnesota R595/GSA, synthesizing the plague capsule antigen in experimental plague in mice].
Gremiakova TA; Stepanshina VN; Korobova OV; Anisimov GA
Mol Gen Mikrobiol Virusol; 1994; (1):23-6. PubMed ID: 8133846
[TBL] [Abstract][Full Text] [Related]
14. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
Eyles JE; Butcher WA; Titball RW; Hill J
Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
[TBL] [Abstract][Full Text] [Related]
15. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge.
Palin A; Chattopadhyay A; Park S; Delmas G; Suresh R; Senina S; Perlin DS; Rose JK
Vaccine; 2007 Jan; 25(4):741-50. PubMed ID: 16959385
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
[TBL] [Abstract][Full Text] [Related]
17. Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.
Tacket CO; Galen J; Sztein MB; Losonsky G; Wyant TL; Nataro J; Wasserman SS; Edelman R; Chatfield S; Dougan G; Levine MM
Clin Immunol; 2000 Nov; 97(2):146-53. PubMed ID: 11027455
[TBL] [Abstract][Full Text] [Related]
18. Small protective fragments of the Yersinia pestis V antigen.
Vernazza C; Lingard B; Flick-Smith HC; Baillie LW; Hill J; Atkins HS
Vaccine; 2009 May; 27(21):2775-80. PubMed ID: 19366573
[TBL] [Abstract][Full Text] [Related]
19. Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis).
Rocke TE; Iams KP; Dawe S; Smith SR; Williamson JL; Heisey DM; Osorio JE
Vaccine; 2009 Dec; 28(2):338-44. PubMed ID: 19879228
[TBL] [Abstract][Full Text] [Related]
20. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]